With 0.51 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.71 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $163.83 whereas the lowest price it dropped to was $160.0652. The 52-week range on DVA shows that it touched its highest point at $168.50 and its lowest point at $75.47 during that stretch. It currently has a 1-year price target of $157.29. Beta for the stock currently stands at 0.87.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of DVA was up-trending over the past week, with a rise of 0.80%, but this was down by -1.66% over a month. Three-month performance surged to 17.44% while six-month performance rose 21.55%. The stock gained 98.96% in the past year, while it has gained 54.05% so far this year. A look at the trailing 12-month EPS for DVA yields 9.40 with Next year EPS estimates of 11.52. For the next quarter, that number is 2.72. This implies an EPS growth rate of 16.92% for this year and 16.29% for next year. EPS is expected to grow by 18.97% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 51.82%.
Float and Shares Shorts:
At present, 88.82 million DVA shares are outstanding with a float of 80.24 million shares on hand for trading. On 2024-09-30, short shares totaled 5.05 million, which was 602.0 higher than short shares on 1724976000. In addition to Mr. Javier J. Rodriguez as the firm’s CEO & Executive Director, Mr. Joel Ackerman serves as its CFO & Treasurer.
Institutional Ownership:
Through their ownership of 0.50685 of DVA’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, DVA reported revenue of $3186722000.0 and operating income of $500917000.0. The EBITDA in the recently reported quarter was $654580000.0 and diluted EPS was $2.5.
